CS231227B1 - 2,5-pierazindion derivatives - Google Patents

2,5-pierazindion derivatives Download PDF

Info

Publication number
CS231227B1
CS231227B1 CS827012A CS701282A CS231227B1 CS 231227 B1 CS231227 B1 CS 231227B1 CS 827012 A CS827012 A CS 827012A CS 701282 A CS701282 A CS 701282A CS 231227 B1 CS231227 B1 CS 231227B1
Authority
CS
Czechoslovakia
Prior art keywords
prepared
amino
formula
yield
derivatives
Prior art date
Application number
CS827012A
Other languages
Czech (cs)
English (en)
Other versions
CS701282A1 (en
Inventor
Evzen Kasafirek
Jiri Vanzura
Ivan Krejci
Jiri Krepelka
Antonin Dlabac
Martin Valchar
Original Assignee
Evzen Kasafirek
Jiri Vanzura
Ivan Krejci
Jiri Krepelka
Antonin Dlabac
Martin Valchar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Evzen Kasafirek, Jiri Vanzura, Ivan Krejci, Jiri Krepelka, Antonin Dlabac, Martin Valchar filed Critical Evzen Kasafirek
Priority to CS827012A priority Critical patent/CS231227B1/cs
Priority to GB08324683A priority patent/GB2127807B/en
Priority to AT0336683A priority patent/AT388161B/de
Priority to SE8305157A priority patent/SE466654B/sv
Priority to CH5208/83A priority patent/CH655929A5/de
Priority to BE0/211589A priority patent/BE897843A/fr
Priority to YU1952/83A priority patent/YU44751B/xx
Priority to IT23058/83A priority patent/IT1171091B/it
Priority to FR8315599A priority patent/FR2533919B1/fr
Priority to HU833419A priority patent/HU193047B/hu
Priority to JP58181834A priority patent/JPS5989671A/ja
Priority to DE3335891A priority patent/DE3335891C2/de
Publication of CS701282A1 publication Critical patent/CS701282A1/cs
Publication of CS231227B1 publication Critical patent/CS231227B1/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
CS827012A 1982-10-01 1982-10-01 2,5-pierazindion derivatives CS231227B1 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
CS827012A CS231227B1 (en) 1982-10-01 1982-10-01 2,5-pierazindion derivatives
GB08324683A GB2127807B (en) 1982-10-01 1983-09-14 2,5-piperazinediones
AT0336683A AT388161B (de) 1982-10-01 1983-09-21 Verfahren zur herstellung von neuen 2,5-piperazindionderivaten
SE8305157A SE466654B (sv) 1982-10-01 1983-09-23 Biologiskt aktiva 2,5-piperazindionderivat, saett foer framstaellning daerav samt farmaceutiska kompositioner innehaallande desamma
CH5208/83A CH655929A5 (de) 1982-10-01 1983-09-26 Biologisch wirksame 2,5-piperazindionderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zubereitungen.
BE0/211589A BE897843A (fr) 1982-10-01 1983-09-27 Derives biologiquement actifs de 2, 5-piperazinediones, procede pour leur preparation et compositions pharmaceutique en contenant
YU1952/83A YU44751B (en) 1982-10-01 1983-09-29 Process for making biologically active derivatives
IT23058/83A IT1171091B (it) 1982-10-01 1983-09-29 Derivati di 2,5-piperazindione biologicamente attivi,processi per la loro preparazione e composizioni farmaceutiche che li contengono
FR8315599A FR2533919B1 (fr) 1982-10-01 1983-09-30 Derives a activite biologique de la 2,5-piperazinedione, procedes pour leur preparation et compositions pharmaceutiques les contenant
HU833419A HU193047B (en) 1982-10-01 1983-09-30 Process for preparing biologically active 2,5-piperazine-dione derivatives
JP58181834A JPS5989671A (ja) 1982-10-01 1983-10-01 ２，５−ピペラジンジオン誘導体
DE3335891A DE3335891C2 (de) 1982-10-01 1983-10-03 2,5-Dioxopiperazinderivate, ihre Herstellung und ihre pharmazeutische Verwendung

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS827012A CS231227B1 (en) 1982-10-01 1982-10-01 2,5-pierazindion derivatives

Publications (2)

Publication Number Publication Date
CS701282A1 CS701282A1 (en) 1984-01-16
CS231227B1 true CS231227B1 (en) 1984-10-15

Family

ID=5418454

Family Applications (1)

Application Number Title Priority Date Filing Date
CS827012A CS231227B1 (en) 1982-10-01 1982-10-01 2,5-pierazindion derivatives

Country Status (12)

Country Link
JP (1) JPS5989671A (fr)
AT (1) AT388161B (fr)
BE (1) BE897843A (fr)
CH (1) CH655929A5 (fr)
CS (1) CS231227B1 (fr)
DE (1) DE3335891C2 (fr)
FR (1) FR2533919B1 (fr)
GB (1) GB2127807B (fr)
HU (1) HU193047B (fr)
IT (1) IT1171091B (fr)
SE (1) SE466654B (fr)
YU (1) YU44751B (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013020527A1 (fr) 2011-08-11 2013-02-14 University Of Veterinary And Pharmaceutical Sciences Brno Faculty Of Pharmacy Utilisation d'alaptide en tant que modificateur de pénétration transdermique dans des compositions pharmaceutiques pour des applications humaines et vétérinaires contenant des médicaments anti-inflammatoires et/ou des agents chimiothérapeutiques antimicrobiens
WO2014019556A1 (fr) 2012-08-02 2014-02-06 University Of Veterinary And Pharmaceutical Sciences Brno Faculty Of Pharmacy Alaptide : procédé de solubilisation, et de modification de la perméation membranaire, et compositions pharmaceutiques pour applications humaines et/ou vétérinaires

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS277405B6 (en) * 1986-06-12 1993-03-17 Vyzk Ustav Farm Biochem Sp Peptides with 1-amino-1-cycloalkane carboxylic acid
US5182285A (en) * 1986-11-07 1993-01-26 Spojene Podniky Pro Zdravotnickou Vyrobu Cell-protective composition for preventing or treating of peptic ulcer
GB8822674D0 (en) * 1988-09-27 1988-11-02 Tate & Lyle Plc Preparation of acylated sucrose derivatives
US7202279B1 (en) * 1998-02-11 2007-04-10 Georgetown University Cyclic dipeptides and azetidinone compounds and their use in treating CNS injury and neurodegenerative disorders
JP4721087B2 (ja) 1999-12-03 2011-07-13 小野薬品工業株式会社 トリアザスピロ［５．５］ウンデカン誘導体およびそれらを有効成分とする薬剤
WO2002074769A1 (fr) * 2001-03-19 2002-09-26 Ono Pharmaceutical Co., Ltd. Medicaments contenant comme principe actif des derives du triazaspiro [5.5] undecane
JP4047365B2 (ja) 2006-01-11 2008-02-13 生化学工業株式会社 シクロアルカンカルボキサミド誘導体及びその製造方法
WO2007080884A1 (fr) * 2006-01-11 2007-07-19 Seikagaku Corporation Derive d'ester d'acide cycloalkylcarbonylamino et son procede de production
JP3975226B2 (ja) 2006-01-11 2007-09-12 生化学工業株式会社 シクロアルキルカルボニルアミノ酸誘導体及びその製造方法
CN107903303B (zh) * 2017-11-20 2021-06-04 陕西慧康生物科技有限责任公司 一种环肽Alaptide的液相合成方法

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1459488A (en) * 1974-03-19 1976-12-22 Wyeth John & Brother Ltd Piperazinedione derivatives

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013020527A1 (fr) 2011-08-11 2013-02-14 University Of Veterinary And Pharmaceutical Sciences Brno Faculty Of Pharmacy Utilisation d'alaptide en tant que modificateur de pénétration transdermique dans des compositions pharmaceutiques pour des applications humaines et vétérinaires contenant des médicaments anti-inflammatoires et/ou des agents chimiothérapeutiques antimicrobiens
WO2014019556A1 (fr) 2012-08-02 2014-02-06 University Of Veterinary And Pharmaceutical Sciences Brno Faculty Of Pharmacy Alaptide : procédé de solubilisation, et de modification de la perméation membranaire, et compositions pharmaceutiques pour applications humaines et/ou vétérinaires

Also Published As

Publication number Publication date
JPH0526782B2 (fr) 1993-04-19
CS701282A1 (en) 1984-01-16
DE3335891A1 (de) 1984-04-05
YU44751B (en) 1991-02-28
SE8305157L (sv) 1984-04-02
YU195283A (en) 1986-10-31
FR2533919B1 (fr) 1986-10-03
BE897843A (fr) 1984-01-16
GB2127807B (en) 1987-02-25
IT8323058A0 (it) 1983-09-29
AT388161B (de) 1989-05-10
GB8324683D0 (en) 1983-10-19
SE8305157D0 (sv) 1983-09-23
FR2533919A1 (fr) 1984-04-06
ATA336683A (de) 1988-10-15
IT8323058A1 (it) 1985-03-29
JPS5989671A (ja) 1984-05-23
SE466654B (sv) 1992-03-16
CH655929A5 (de) 1986-05-30
HU193047B (en) 1987-08-28
GB2127807A (en) 1984-04-18
IT1171091B (it) 1987-06-10
DE3335891C2 (de) 1993-11-11

Similar Documents

Publication Publication Date Title
AU2016349080B2 (en) 7-(thiazol-5-yl) pyrrolopyrimidine compound as TLR7 agonist
SU1349700A3 (ru) Способ получени (2-оксо-1,2,3,5-тетрагидроимидазо-/2,1- @ /хиназолинил)оксиалкиламидов,их оптических изомеров или фармакологически приемлемых солей с кислотами
KR100226311B1 (ko) 에리트로마이신 유도체
CS237311B2 (en) Processing of carboxyalkyldipeptide
CS231227B1 (en) 2,5-pierazindion derivatives
JPH07121955B2 (ja) アミノ酸誘導体およびその製法
CS621585A2 (en) Method of analynprolinone derivatives production
HU186983B (en) Process for preparing new 3-amino-5-pregnene derivatives and salts thereof
EP0351561B1 (fr) Esters d'estramustine
US5298499A (en) S-2-(substituted ethylamino)ethyl phosphorothioates
PT95629A (pt) Processo para a preparacao de compostos de adenosina n-(6)substituida
FR2549051A1 (fr) Nouveaux agents radioprotecteurs ayant une structure amino-thioalkyle et procede pour leur preparation
CA1202317A (fr) Thioesters de l'acide acetylsalicylique, procede de preparation et composes pharmaceutiques les contenant
PT87428B (pt) Processo para a preparacao de derivados de 4-bezil-1-(2h)-ftalazinona com um radical de aminoacido e de composicoes farmaceuticas que os contem
EP0318091B1 (fr) Dérivés optiquement résolus de l'amino-pyrrolidine neuroprotecteurs
EP0515995A2 (fr) N-(5-thioxo-L-propyl)-L-cystéine et dérivés, leur préparation et compositions pharmaceutiques les contenants
KR900004148B1 (ko) 피롤로[1,2-a][4,1]벤즈옥사제핀 유도체
US3767674A (en) Cyclohexeno thioxanthones
JPS6230762A (ja) 新規５−オキソ−１−イミダゾリジンアセトアミド誘導体
KR850001880B1 (ko) 트란스-4-[n-(3', 4'-메틸렌디옥시벤질리덴)아미노메틸] 사이클로헥산-1-카복실산 및 이의 유도체의 제조방법
US20070116665A1 (en) Novel derivatives of morphine-6-glucuronide, pharmaceutical compositions containing them, their preparation method and their uses
JPS63502432A (ja) アシル化シアナミド組成物
HU179949B (en) Process for preparing nitroso-carbamide derivatives
KR800001506B1 (ko) 이미다졸기 함유펩티드의 제조방법
KR810000610B1 (ko) 6-(m-아미노페닐)-2, 3, 5, 6-테트라하이드로 이미다조[2, 1-b] 티아졸 유도체의 제조방법